Therapeutic Giving: Pulmonary Arterial Hypertension Grant

The Therapeutic Giving program by Johnson & Johnson Innovative Medicine focuses on Pulmonary Arterial Hypertension and supports nonprofit organizations that enhance patient access to treatment and services. Eligible applicants must be IRS 501(c)(3) certified and prioritize innovative programs with measurable outcomes. Funding is aimed at addressing health disparities and improving patient care through education, advocacy, and direct services. Applications are accepted from January 1 to October 15, with a preference for initiatives over event-based requests.

NOTE:

• Application period is January 1 – October 15.For event-specific funding, applications must be submitted at least sixty (60) days prior to the event.
• About Us

Janssen is interested in funding programs and initiatives that improve patient access to treatment and services, advance health equity and strengthen frontline health workforces within the therapeutic areas noted.
Our preference is in support of programs focused on health system improvement with measurable outcomes over fundraising activities.
Areas of Interest
Early diagnosis and disease interventionDisease awareness and education of patients and caregiversFamily/caregiver support, wellness education, advocacy supportInnovative efforts to empower patients to manage their diseaseTools to assist patients and families related to therapy to improve quality of lifeEfforts to build skills of professionals and caregivers to improve patient outcomesEfforts to address healthcare disparities for marginalized or at-risk groups (outreach and awareness, education to policy makers, stigma and cultural competence initiatives)Direct patient services or linkage to care, disease screeningsOutreach to those without access to medical care or poor accessAdvocacy initiatives on access to care to treat individual patient needs

Eligibility

Only nonprofit organizations classified by the IRS as 501 (c)(3) are eligible to apply for a charitable contribution.All contribution requests are reviewed for compliance with our policies and relevant legal and industry requirements, including guidelines set forth by the Food and Drug Administration (FDA) and the Pharmaceutical Research and Manufacturers of America (PhRMA).Applications are evaluated competitively with emphasis given to innovative programs with measurable outcomes that address disparities or areas of high unmet need.Funding decisions will consider prevalence, population served, program design, organizational capacity, and anticipated outcomes.

Ineligibility

Faxed, e-mailed and postal-mailed requests will not be considered. Some requests or categories may not meet our guidelines for giving. These exclusions include the following:Organizations that do not have a valid non-profit, tax-exempt statusLoansTrips or toursSectarian and religious organizations that do not serve the general public on a nondenominational basisCapital requests (building funds, endowments, multi-year commitments) are generally not supportedPolitical groupsAdvocacy activities directed towards specific legislationOrganizations whose missions/objectives do not meet our contributions guidelinesDonations to individuals or to a charity on behalf of a customerEducational grants for healthcare professionals; see instead our education grants program for our funding priorities in this area.Research grantsCommercial Co-Ventures (CCV)